Are there cannabinoids that you need reference materials for? - EUFORiaR

It is essential that potentially harmful new psychoactive substances (NPS) emerging on the recreational drug market are rapidly identified, evaluated and risk assessed.

For unequivocal analytical identification of substances, suitably characterised Reference Materials (RM) are typically required. The lag time in the availability of RM can result in critical delays in legislative and public health responses to substances of concern.

The Eurostars EUFORiaR project aims to address the shortfall in RMs and to shorten RM availability timelines using an established Predictive Parallel Production Platform (4P) synthesis approach and triangulation of substance emergence data from a variety of sources, including customer insights.

Are you confident in your detection of new cannabinoid substances?

Are there compounds you are desperately seeking standards for, but are finding difficult to source?

Which direction do you see the illicit market taking next? Are you already seeing early indications of change?

We'd love to hear your opinions! Complete our survey below and let us know!
- Name*
  
  First NameLast Name
- Company Name*
- Job Title*
- Email*
  example@example.com
- Phone Number
- Which focus area do you work in?
  
  AcademicPost-mortem toxicologyForensic toxicologyClinical toxicologyOther - please specify
- Are you currently screening for any of the following:
  
  Traditional phytocannabinoids (e.g. delta-9-THC)Semi-synthetic cannabinoids (e.g. delta-8-THC , delta-10-THC, HHC, HHC-H, HHC-P)Synthetic cannabinoids (e.g. MDMB-4en-PINACA, ADB-BUTINACA)
- Do you feel confident in your labs ability to detect new emerging cannabinoids?
  
  YesNoUnsure
- What drives the scope of your screening methods? Order from highest to least influence:
- Do you retire old compounds from your analytical methods when NPS trends move on? i.e. First generation synthetic cannabinoids
  
  YesNoUnsure
- Do you feel that Reference Material Producers are meeting the current need in relation to;
- 1) Availability of cannabinoid reference materials
  
  YesNoUnsure
- 2) Speed to market
  
  YesNoUnsure
- What would you like to see more of? Order from high to low preference
- Which cannabinoids (phyto/semi-synthetic/synthetic) are you detecting most frequently?
- Using your own experiences and knowledge of the cannabinoid market, which cannabinoid compounds to you think will increase or decrease in prevalence? And what types of new substances do you think will emerge next on the market?
- Would you be interested in a quarterly subscription service for supply of novel psychoactive substances, including emerging cannabinoids, sharing cost with other participants?
  
  YesNoNeed more information
- Please let us know if you have any additional comments, questions or recommendations:
- Should be Empty: